|
DE144266C
(US07714131-20100511-C00001.png)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
*
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
US8048869B2
(en)
|
2001-05-18 |
2011-11-01 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
|
ATE449606T1
(de)
|
2001-05-23 |
2009-12-15 |
Pantarhei Bioscience Bv |
Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
|
|
PT1390042E
(pt)
|
2001-05-23 |
2008-03-10 |
Pantarhei Bioscience Bv |
Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
WO2003041718A1
(en)
|
2001-11-15 |
2003-05-22 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
DE60215224T2
(de)
|
2002-02-21 |
2007-08-23 |
Schering Aktiengesellschaft |
Pharmazeutische zusammensetzung, enthaltend ein oder mehrere steroide, eine oder mehrere tetrahydrofolatverbindungen und vitamin b12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
US7943604B2
(en)
|
2002-06-11 |
2011-05-17 |
Pantarhei Bioscience B.V. |
Method of treating human skin and a skin care composition for use in such a method
|
|
US7923440B2
(en)
|
2002-06-11 |
2011-04-12 |
Pantarhei Bioscience B.V. |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
|
|
AU2003253506A1
(en)
|
2002-07-12 |
2004-02-02 |
Pantarhei Biosciences B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
SI1556058T1
(sl)
|
2002-10-23 |
2008-02-29 |
Pantarhei Bioscience Bv |
Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
|
|
US20060211669A1
(en)
*
|
2002-11-08 |
2006-09-21 |
Verhaar Mark T |
Synthesis of estetrol via estrone derived steroids
|
|
DE602004002591T9
(de)
|
2003-05-22 |
2008-01-03 |
Pantarhei Bioscience B.V. |
Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
|
|
CN101189251B
(zh)
|
2005-05-26 |
2012-09-12 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
|
CN101228268A
(zh)
|
2005-07-25 |
2008-07-23 |
德累斯顿工业大学 |
Rna扩增和/或rna标记用的rna依赖的rna聚合酶，方法及试剂盒
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
US20090221540A1
(en)
|
2006-01-09 |
2009-09-03 |
Pantarhei Bioscience B.V. |
Method of Treating An Acute Vascular Disorder
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
CN101443015A
(zh)
|
2006-06-08 |
2009-05-27 |
沃纳奇尔科特公司 |
具有改善的生物利用率的乙炔雌二醇及其药物前体的固体剂型的给药方法
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
PE20081301A1
(es)
|
2006-11-29 |
2008-10-01 |
Wyeth Corp |
Tabletas de bi-capa de estrogeno/moduladores selectivos de receptores de estrogeno (serm) y estrogeno/progestina
|
|
US7867515B2
(en)
|
2006-12-20 |
2011-01-11 |
TEVA Woman's Health, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
CA2674325A1
(en)
*
|
2007-01-08 |
2008-07-17 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
|
JP2010515758A
(ja)
|
2007-01-12 |
2010-05-13 |
ワイス エルエルシー |
錠剤中錠剤組成物
|
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
|
US8518923B2
(en)
|
2007-07-19 |
2013-08-27 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
EP2085373B8
(en)
|
2007-08-31 |
2013-06-26 |
National University Corporation Nagoya University |
Method for producing carbonyl compound and pro-oxidant used for production of carbonyl compound
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
CN107266514A
(zh)
|
2011-06-01 |
2017-10-20 |
埃斯特拉私人有限责任公司 |
用于产生雌四醇中间体的方法
|
|
EA025511B1
(ru)
|
2011-06-01 |
2016-12-30 |
Эстетра С.П.Р.Л. |
Способ получения промежуточных соединений эстетрола
|
|
EP2383279A1
(en)
*
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
KR102033187B1
(ko)
|
2011-07-19 |
2019-10-16 |
판타레이 바이오사이언스 비.브이. |
디하이드로에피안드로스테론(ｄｈｅａ)을 함유하는 정제
|
|
PT2741824T
(pt)
|
2011-08-11 |
2017-07-06 |
Estetra Sprl |
Utilização de estetrol como contracetivo de emergência
|
|
KR20140061438A
(ko)
|
2011-09-16 |
2014-05-21 |
훼링 비.브이. |
속용성 약학 조성물
|
|
US8987484B2
(en)
|
2011-10-07 |
2015-03-24 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6254289B2
(ja)
|
2013-09-18 |
2017-12-27 |
クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． |
エステトロールの製造プロセス
|
|
NZ720906A
(en)
|
2013-12-12 |
2022-04-29 |
Estetra Sprl |
Orally disintegrating solid dosage unit containing an estetrol component
|
|
UA123098C2
(uk)
|
2015-06-18 |
2021-02-17 |
Естетра Спрл |
Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
|
|
EP3310346B1
(en)
|
2015-06-18 |
2021-03-24 |
Estetra SPRL |
Orodispersible tablet containing estetrol
|
|
EA035687B1
(ru)
|
2015-06-18 |
2020-07-27 |
Эстетра Спрл |
Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
|
|
DK3310345T3
(da)
|
2015-06-18 |
2021-05-25 |
Estetra Sprl |
Orodispersibel tablet indeholdende estetrol
|
